Becton Dickinson and Company (BDX) New York Stock Exchange
230.784.401.94%
CloseJanuary 15, 2019

News: updated – 16-Jan 01:34


Consider Becton, Dickinson As Bard Deal Drives Value14-Jan 06:14(SeekingAlpha)

It is not often that investors see aggressive capital allocation in the life sciences space, with the notable exception of Valeant and Allergan ( AGN ), but Becton, Dickinson ( BDX ) CEO Vince Forlenza is quietly demonstrating characteristics of an "outsider" CEO as he continues to aggressivel…

BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call8-Jan 04:30(PR Newswire)

FRANKLIN LAKES, N.J. , Jan. 8, 2019 /PRNewswire/ –BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2019 earnings conference call on Tuesday, February 5, 2019 , at 8:00 a.m. (ET) . BD will issue a press r…

My K.I.S.S. Dividend Growth Portfolio: 4th Quarter 2018 Update8-Jan 02:41(SeekingAlpha)

There are many reasons why I believe a well constructed dividend growth portfolio will beat the market over time. One of the main ones is that many dividend growth stocks are often considered to be defensive stocks which have a low beta and will fall less than the market does d…

AngioDynamics Continuing To Slowly Shift Its Mix Towards Growth8-Jan 10:07(SeekingAlpha)

Following AngioDynamics ( ANGO ) may be a little like watching paint dry given the low growth rate (often a severe valuation-limiting issue in med-tech), but the stock has at least outperformed the average med-tech stock since my last write-up in July and has outperformed more significantl…

Dividend Growth 50: More In Year 4, With Income Up 10% – Part 28-Jan 09:00(SeekingAlpha)

As if it wasn’t enough that the Dividend Growth 50 beat the market in total return in 2018, our real-money portfolio also had its best year ever on the income-growing front. How does a 9.87% raise sound? Pretty darn good, if you ask me – and rounding it up to 10% sounds even better! Not ev…